Retrospectively registered randomized controlled trial (RCT) study sought to investigate the effects of a six-week art psychotherapy in the treatment of 49 adult patients already receiving pharmacotherapy for major depressive disorder (MDD). To achieve this objective, the combined therapy’s primary effects on depressive symptoms, anxiety, interpersonal relationships, and self-esteem were examined, along with its secondary effects on drop-out rate, remission rate, and treatment satisfaction Results showed that the combined therapy was significantly more effective than pharmacotherapy alone in alleviating symptoms of depression (p < .05) and anxiety (p < .05), improving interpersonal relationships (p < .05), and increasing self-esteem (p < .05). However, no significant changes occurred in drop-out rate (p> .05), remission rate, and treatment satisfaction (p < .05). These findings also support the result of previous studies reporting on the efficacy of combined psychotherapy and pharmacotherapy in the treatment of MDD. However, no significant changes occurred in drop-out rate, remission rate, or treatment satisfaction. Based on these results, art psychotherapy is an effective integrative medicine to alleviate various symptoms of patients with MDD.

回顾性注册的随机对照试验（RCT）研究试图研究六周的艺术心理治疗对已经接受药物治疗的重度抑郁症（MDD）的49名成人患者的治疗效果。为了达到这个目的，研究了联合疗法对抑郁症状，焦虑，人际关系和自尊的主要作用，以及对辍学率，缓解率和治疗满意度的次要作用。在缓解抑郁症（p <.05）和焦虑症（p <.05），改善人际关系（p <.05）和增加自尊（p <.05）方面，比单独药物治疗有效得多。但是，辍学率（p> .05），缓解率，和治疗满意度（p <.05）。这些发现也支持以前的研究结果，该研究报告了心理疗法和药物疗法联合治疗MDD的功效。但是，辍学率，缓解率或治疗满意度没有明显变化。基于这些结果，艺术心理治疗是缓解MDD患者各种症状的有效综合药物。